PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-60.36%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-55.68%
Negative gross profit growth while 6247.T is at 8.58%. Joel Greenblatt would examine cost competitiveness or demand decline.
-110.17%
Negative EBIT growth while 6247.T is at 54.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-112.99%
Negative operating income growth while 6247.T is at 19.72%. Joel Greenblatt would press for urgent turnaround measures.
-120.93%
Negative net income growth while 6247.T stands at 74.26%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-120.93%
Negative EPS growth while 6247.T is at 74.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-120.93%
Negative diluted EPS growth while 6247.T is at 74.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.53%
Negative 10Y revenue/share CAGR while 6247.T stands at 29.24%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
125.84%
5Y revenue/share CAGR above 1.5x 6247.T's 42.70%. David Dodd would look for consistent product or market expansions fueling outperformance.
89.60%
3Y revenue/share CAGR above 1.5x 6247.T's 50.86%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
100.00%
Positive long-term OCF/share growth while 6247.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.45%
Similar net income/share CAGR to 6247.T's 96.37%. Walter Schloss would see parallel tailwinds or expansions for both firms.
-10.61%
Negative 5Y net income/share CAGR while 6247.T is 129.37%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
25.19%
Positive short-term CAGR while 6247.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
57.75%
5Y equity/share CAGR above 1.5x 6247.T's 13.87%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
42.85%
3Y equity/share CAGR above 1.5x 6247.T's 11.51%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.41%
Firm’s AR is declining while 6247.T shows 7.06%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.22%
Inventory growth well above 6247.T's 12.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.43%
Positive asset growth while 6247.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
24.55%
Debt growth of 24.55% while 6247.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-25.50%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.10%
We cut SG&A while 6247.T invests at 3.68%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.